Latest News and Press Releases

HOUSTON, TX, April 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – AngioSoma, Inc. (OTC: SOAN) announces that Diabetes Relief LLC has licensed a new facility in San Antonio, Texas for its patented...

Houston, TX, March 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma, Inc. (OTC: SOAN) announced today the Company is excited about recent news of accomplishments of Diabetes Relief LLC,...

Houston, TX, Dec. 14, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma, Inc. (OTC: SOAN) announced today the Company has entered into a partially binding letter of intent to acquire 100% of...

Peripheral Artery Disease Device Manufacturer Targeted for Joint Venture HOUSTON, Nov. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma (OTC: SOAN), a leading biotechnology research and...

Heart Health Focused Campaign Set to Kick Off December 1st, 2018 HOUSTON, TX, Nov. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – AngioSoma (OTC: SOAN), a leading biotechnology research and...

New Industry Data and Product Roadmap Align for Optimistic Outlook HOUSTON, Nov. 08, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma (OTC: SOAN), a leading biotechnology research and...

Research and Development Focus on Natural Skin Products for Women and Men HOUSTON, Oct. 25, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma (OTC: SOAN), a leading biotechnology research and...

New StemStrength Deluxe™ Available at NPC Texas Legends Championships in Dallas, Texas HOUSTON, Oct. 24, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma (OTC: SOAN), a leading biotechnology...

SomaCeuticals, an AngioSoma Inc. Subsidiary, Leverages Online Retail Giant for New Deluxe Formula of its Flagship Product HOUSTON, TX, Oct. 22, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE –...

Houston, TX, Oct. 18, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma (OTC: SOAN), a leading pharmaceutical research and development company, announces that trademarks have been awarded for...